4.6 Review

The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai et al.

Summary: In highly glycolytic tumors, regulatory T (Treg) cells have higher PD-1 expression compared to effector T cells. Under low-glucose conditions, Treg cells actively absorb lactic acid through monocarboxylate transporter 1 (MCT1), promoting the expression of PD-1, while PD-1 expression by effector T cells is dampened. PD-1 blockade invigorates PD-1-expressing Treg cells, resulting in treatment failure.

CANCER CELL (2022)

Article Gastroenterology & Hepatology

Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism

Honglin Jiang et al.

Summary: MEK and autophagy co-inhibition coupled with CD40 agonism activates the STING/type I interferon pathway and enhances immunogenicity of tumor-associated macrophages in pancreatic ductal adenocarcinoma (PDA) cells. This treatment strategy achieves cytotoxic T-cell activation and enhances antitumor immunity in an immunologically cold mouse PDA model.

GASTROENTEROLOGY (2022)

Article Cell Biology

Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death

Changfeng Li et al.

Summary: The study reveals that zalcitabine, an antiviral drug, can suppress pancreatic cancer cell growth through inducing ferroptosis, a type of cell death. This effect is mediated by zalcitabine-induced mitochondrial DNA stress and the activation of a DNA sensing pathway, leading to cell death via lipid peroxidation. Genetically or pharmacologically inhibiting this pathway reduces the anticancer effects of zalcitabine.

AUTOPHAGY (2021)

Article Gastroenterology & Hepatology

Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4

Soledad A. Camolotto et al.

Summary: The study found that HNF4α regulates the growth and molecular subtype of PDAC by activating the classical gene expression program and repressing SIX4 and SIX1.
Article Medicine, Research & Experimental

Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity

Shen Li et al.

Summary: The authors successfully reproduced the systemic toxicity and multiorgan involvement induced by SARS-CoV-2 in a mouse model through viral delivery, revealing that metabolic and epigenetic changes could contribute to the pathogenesis of COVID-19.

JCI INSIGHT (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Metabolic support of tumour-infiltrating regulatory T cells by lactic acid

McLane J. Watson et al.

Summary: T-reg cells exhibit broad heterogeneity in glucose metabolism within normal and transformed tissues, utilizing an alternative metabolic pathway to maintain their suppressive function and proliferation. Glucose uptake is correlated with poorer suppressive function and long-term instability, while high-glucose conditions impair T-reg cell function and stability. Additionally, T-reg cells upregulate pathways involved in the metabolism of lactic acid, with lactate uptake being dispensable for peripheral T-reg cells but required intratumorally for slowed tumor growth and increased response to immunotherapy.

NATURE (2021)

Article Multidisciplinary Sciences

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

Nan Xiao et al.

Summary: Metabolomic data and cytokine/chemokine profiling from stratified COVID-19 patients suggest a correlation between arginine, tryptophan, and purine metabolic pathways with hyperinflammation, potentially offering therapeutic targets for severe COVID-19 patients. Modulating metabolism can significantly impact the release of proinflammatory cytokines by peripheral blood mononuclear cells, indicating a potential strategy for treating fatal cytokine release syndrome in COVID-19.

NATURE COMMUNICATIONS (2021)

Review Oncology

Metabolic Codependencies in the Tumor Microenvironment

Prasenjit Dey et al.

Summary: Cancer cell metabolic reprogramming is driven by signals from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, while extrinsic signals fine-tune metabolic processes based on metabolite availability and cellular requirements. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on cancer genotype, tumor microenvironment composition, and tissue location.

CANCER DISCOVERY (2021)

Article Oncology

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

George Sharbeen et al.

Summary: High expression of SLC7A11 in human PDAC tumor stroma, independently prognostic of poorer overall survival. The study demonstrates that PDAC-derived CAFs are highly dependent on SLC7A11 for cystine uptake and glutathione synthesis. Inhibition of SLC7A11 decreases CAF proliferation, reduces their resistance to oxidative stress, and inhibits their ability to support PDAC cell growth.

CANCER RESEARCH (2021)

Article Immunology

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia

Joseph E. Rupert et al.

Summary: The study revealed that most patients with pancreatic adenocarcinoma suffer from cachexia, which is mainly due to tissue crosstalk mediated via IL-6 signaling affecting muscle and adipocytes, providing targetable mechanisms for cachexia treatment.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Review Gastroenterology & Hepatology

Harnessing metabolic dependencies in pancreatic cancers

Joel Encarnacion-Rosado et al.

Summary: PDAC is a highly aggressive cancer with unique tumor microenvironment, which can reprogram metabolism to adapt to the harsh conditions and develop therapeutic resistance. PDAC cells survive in the hostile environment by using non-canonical metabolic pathways and scavenging pathways.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis

Edoardo Del Poggetto et al.

Summary: Inflammation plays a key role in promoting pancreatic ductal adenocarcinoma (PDAC), especially in the presence of KRAS mutations. Researchers have found that a transient inflammatory event can prime pancreatic epithelial cells for subsequent transformation by oncogenic KRAS, even long after the inflammation has resolved. This adaptation allows for the reactivation of acinar-to-ductal metaplasia (ADM) in response to recurring inflammatory events, potentially offering a protective mechanism against tissue damage.

SCIENCE (2021)

Article Multidisciplinary Sciences

GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis

Daniel M. Kremer et al.

Summary: Cancer metabolism is rewired to support cell survival, with targeting metabolic dependencies following GOT1 inhibition leading to ferroptosis, an iron-dependent form of cell death. The study identifies a biochemical connection between GOT1, iron regulation, and ferroptosis in pancreatic cancer cells.

NATURE COMMUNICATIONS (2021)

Review Oncology

Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids

Erica Pranzini et al.

Summary: This study emphasizes the important role of amino acid metabolic reprogramming in cancer therapy, with amino acids playing a crucial role in acquiring resistance to anticancer drugs, especially in terms of the resistance of cancer stem cells.

TRENDS IN CANCER (2021)

Review Oncology

Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment

Samuel A. Kerk et al.

Summary: Mutant KRAS drives common metabolic programmes in colon, lung, and pancreatic tumors, but its impact is also influenced by tumor suppressor losses and specific physiological features of cells and tissues.

NATURE REVIEWS CANCER (2021)

Article Medicine, General & Internal

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

Gerald Falchook et al.

Summary: The study aimed to determine the MTD and RP2D of oral FASN inhibitor TVB-2640 and evaluate its safety and efficacy in monotherapy and in combination with paclitaxel. Results showed potent FASN inhibition with manageable toxicity primarily affecting skin and eyes, supporting further investigation particularly in KRASMUT lung, ovarian, and breast cancer patients.

ECLINICALMEDICINE (2021)

Editorial Material Oncology

Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer

Kamiya Mehla et al.

CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer

Wan Hua et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Review Gastroenterology & Hepatology

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

Louis Buscail et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Oncology

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Erin Helms et al.

Cancer Discovery (2020)

Review Medicine, General & Internal

Recent insights into the biology of pancreatic cancer

Wantong Yao et al.

EBIOMEDICINE (2020)

Review Biochemistry & Molecular Biology

Fibrosis and cancer: A strained relationship

Bram Piersma et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Multidisciplinary Sciences

Cysteine depletion induces pancreatic tumor ferroptosis in mice

Michael A. Badgley et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Keisuke Yamamoto et al.

NATURE (2020)

Article Multidisciplinary Sciences

IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models

Shao-Wei Lu et al.

NATURE COMMUNICATIONS (2020)

Review Medicine, General & Internal

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification

Pilar Espiau-Romera et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer

Robert S. Banh et al.

Article Cell Biology

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

Christopher J. Halbrook et al.

CELL METABOLISM (2019)

Review Biochemistry & Molecular Biology

Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity

Andrea Padoan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Jae W. Lee et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant et al.

NATURE MEDICINE (2019)

Article Biochemistry & Molecular Biology

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers

Conan G. Kinsey et al.

NATURE MEDICINE (2019)

Article Oncology

A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression

Francesca R. Auciello et al.

CANCER DISCOVERY (2019)

Article Oncology

Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis

Yasuyuki Mizutani et al.

CANCER RESEARCH (2019)

Review Oncology

Checkpoint inhibitors in pancreatic cancer

Andreas Henriksen et al.

CANCER TREATMENT REVIEWS (2019)

Review Oncology

Cytokines in clinical cancer immunotherapy

Pedro Berraondo et al.

BRITISH JOURNAL OF CANCER (2019)

Review Oncology

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Prashanth Rawla et al.

WORLD JOURNAL OF ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Autophagy and proinflammatory cytokines: Interactions and clinical implications

Yun Ge et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2018)

Article Gastroenterology & Hepatology

Plasma inflammatory cytokines and survival of pancreatic cancer patients

A. Babic et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis

Naiara Santana-Codina et al.

NATURE COMMUNICATIONS (2018)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Multidisciplinary Sciences

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

Orianne Olivares et al.

NATURE COMMUNICATIONS (2017)

Review Biochemistry & Molecular Biology

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Brent R. Stockwell et al.

Review Biochemistry & Molecular Biology

Targeting Metabolism for Cancer Therapy

Alba Luengo et al.

CELL CHEMICAL BIOLOGY (2017)

Article Oncology

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Andrew J. Aguirre et al.

CANCER CELL (2017)

Review Oncology

Autophagy and inflammation

Mengjia Qian et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2017)

Review Cell Biology

Autophagy and Tumor Metabolism

Alec C. Kimmelman et al.

CELL METABOLISM (2017)

Article Biochemistry & Molecular Biology

6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panci cells in vitro

Abdullah Yalcin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Oncology

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation

Zhuonan Zhuang et al.

CLINICAL CANCER RESEARCH (2016)

Article Multidisciplinary Sciences

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Cristovao M. Sousa et al.

NATURE (2016)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Review Cell Biology

ROS homeostasis and metabolism: a dangerous liason in cancer cells

E. Panieri et al.

CELL DEATH & DISEASE (2016)

Article Cell Biology

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

Bruno Costa-Silva et al.

NATURE CELL BIOLOGY (2015)

Article Multidisciplinary Sciences

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Anneleen Daemen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Oncology

The complex landscape of pancreatic cancer metabolism

Cristovao Marques Sousa et al.

CARCINOGENESIS (2014)

Review Biochemistry & Molecular Biology

KRAS: feeding pancreatic cancer proliferation

Kirsten L. Bryant et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Review Immunology

Metabolic Pathways in Immune Cell Activation and Quiescence

Erika L. Pearce et al.

IMMUNITY (2013)

Article Multidisciplinary Sciences

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Jaekyoung Son et al.

NATURE (2013)

Article Multidisciplinary Sciences

The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia

Rui Kang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Biochemistry & Molecular Biology

Autophagy and cytokines

James Harris

CYTOKINE (2011)

Review Oncology

Regulation of cancer cell metabolism

Rob A. Cairns et al.

NATURE REVIEWS CANCER (2011)

Review Biochemistry & Molecular Biology

Reactive oxygen species in cancer

Geou-Yarh Liou et al.

FREE RADICAL RESEARCH (2010)

Review Oncology

Tumor cell metabolism: Cancer's Achilles' heel

Guido Kroemer et al.

CANCER CELL (2008)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)